8
Oct
2024

XL Laboratories Pvt. Ltd

Exhibitor at CPHI Milan 2024 stand 16G39, Finished Dosage Formulations
About Us

We are a research driven Pharmaceutical Finished Dosage Forms manufacturing company based out of New Delhi, India with 2 manufacturing sites accredited with EU GMP, TGA-Australia (Clearance), ANVISA-Brazil, Thailand FDA, PIC/s, WHO GMP etc.
The manufacturing site are located new the national capital, New Delhi as below:

1. Site 1 @ Bhiwadi for Tablets, Hard Gelatin Capsules, Oral Liquids and Sachets.

2. Site 2 @ Neemrana for Soft Gelatin Capsules.

We offer out licensing, in licensing, contract manufacturing and our development services for analytical & formulations.

XL's products find their footprint in Central & South America, Europe, Africa, Middle East, Indian Subcontinent, South East Asia, Australia and New Zealand. 

Please get in touch with us at [email protected] for detailed information.

  • IN
  • 2015
    On CPHI since
  • 2
    Certificates
  • 250 - 499
    Employees
Company types
CMO/CDMO
Contract Service
Generics/Biosimilars Manufacturer
Manufacturer/Innovator
OTC
Pharmaceutical company
Primary activities
Pharmaceutical Company (generic finished products)
Regulatory Affairs
Contact info
  • 430, DLF Tower, Shivaji Marg,, 110015, New Delhi, India
Event information
CPHI Milan 2024
  • 08 Oct 2024 - 10 Oct 2024
  • Fiera Milano, Italy
  • Visit us at stand 16G39, Finished Dosage Formulations

Products Featured at CPHI Milan 2024